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Abstract
Many studies suggest that far-infrared (FIR) therapy can reduce the frequency of some vascular-related diseases. The non-
thermal effect of FIR was recently found to play a role in the long-term protective effect on vascular function, but its
molecular mechanism is still unknown. In the present study, we evaluated the biological effect of FIR on vascular endothelial
growth factor (VEGF)-induced proliferation in human umbilical vein endothelial cells (HUVECs). We found that FIR ranging
3,10 mm significantly inhibited VEGF-induced proliferation in HUVECs. According to intensity and time course analyses, the
inhibitory effect of FIR peaked at an effective intensity of 0.13 mW/cm
2 at 30 min. On the other hand, a thermal effect did
not inhibit VEGF-induced proliferation in HUVECs. FIR exposure also inhibited the VEGF-induced phosphorylation of
extracellular signal-regulated kinases in HUVECs. FIR exposure further induced the phosphorylation of endothelial nitric
oxide (NO) synthase (eNOS) and NO generation in VEGF-treated HUVECs. Both VEGF-induced NO and reactive oxygen
species generation was involved in the inhibitory effect of FIR. Nitrotyrosine formation significantly increased in HUVECs
treated with VEGF and FIR together. Inhibition of phosphoinositide 3-kinase (PI3K) by wortmannin abolished the FIR-
induced phosphorylation of eNOS and Akt in HUVECs. FIR exposure upregulated the expression of PI3K p85 at the
transcriptional level. We further found that FIR exposure induced the nuclear translocation of promyelocytic leukemia zinc
finger protein (PLZF) in HUVECs. This induction was independent of a thermal effect. The small interfering RNA transfection
of PLZF blocked FIR-increased PI3K levels and the inhibitory effect of FIR. These data suggest that FIR induces the nuclear
translocation of PLZF which inhibits VEGF-induced proliferation in HUVECs.
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Introduction
Infrared radiation is invisible electromagnetic radiation, the
wavelength of which is longer than that of visible light. According
to differences in wavelength, the International Commission on
Illumination (CIE) recommends dividing infrared radiation into
the following three bands: near-infrared radiation (IR-A:
0.7,1.4 mm), middle-infrared radiation (IR-B: 1.4,3 mm), and
far-infrared (FIR) radiation (IR-C: 3,1000 mm). FIR therapy has
the potential to improve endothelial function and reduce the
frequency of some vascular-related diseases [1–5]. Recently, a
clinical study evaluated the effect of FIR therapy on 145
hemodialysis (HD) patients with a native arteriovenous fistula
(AVF), and found that FIR therapy improved inadequate access
flow and survival of the AVF in HD patients through both thermal
and non-thermal effects [6]. That study revealed that the non-
thermal effects of FIR played a role in the long-term protective
effect on vascular function.
The overwhelming disadvantage of an AVF in HD patients is its
propensity for venous stenosis. A histological evaluation revealed
that endothelial and fibromuscular hyperplasia is the leading cause
of venous stenosis [7–9]. Intimal hyperplasia causes AVF intimal
thickening with a large number of endothelial cells and a large
amount of myofibroblast proliferation [9]. Recent studies in a
variety of experimental arterial models of endothelial and smooth
muscle injury suggested that macrophages, endothelial cells, and
smooth muscle cells/myofibroblasts are all involved in the
response to injury that is responsible for the development of
neointimal hyperplasia [10,11]. Potential growth factors and
extracellular matrix proteins are thought to play roles in this
process [12–15]. Vascular endothelial growth factor (VEGF) is
particularly induced by hemodialysis graft placement, and then
increases other mediators to cause the development of venous
stenosis [16]. The influence of FIR on the function of VEGF is a
critical problem in studying the biological activities of FIR on
vascular function.
Many studies revealed that the biological activities of irradiation
with FIR are highly associated with the endothelial nitric oxide
(NO) synthetase (eNOS)/NO pathway. In rat models, the
beneficial effects of FIR therapy on skin blood flow were suggested
to be related to the L-arginine/NO pathway [5]. Akasaki et al.
found that repeated FIR sauna therapy could induce angiogenesis
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[4]. Moreover, Ikeda et al. reported that 4 weeks of FIR sauna
therapy significantly increased eNOS expression and NO
production in cardiomyopathic hamsters with heart failure [2].
However, those studies did not investigate how FIR stimulates the
eNOS/NO pathway. The molecular mechanisms of the biological
activity of FIR irradiation need to be further elucidated.
In this study, we evaluated the biological effect of FIR on
VEGF-induced proliferation in human umbilical vein endothelial
cells (HUVECs). We found that a non-thermal effect of FIR
induced translocation of the transcription factor, promyelocytic
leukemia zinc finger (PLZF) protein, to nuclei, and ultimately
inhibited VEGF-induced proliferation in HUVECs via the
phosphoinositide 3-kinase/Akt signaling pathway.
Materials and Methods
Materials
VEGF and other chemicals of reagent grade were obtained
from Sigma (St. Louis, MO, USA). The primary antibodies for
PI3K p85, Akt, phospho-Akt (Ser 473), ERK1/2, phospho-
ERK1/2 (Thr 202/Tyr 204), eNOS, and phospho-eNOS (Ser
1177) were purchased from Cell Signaling (Danvers, MA, USA).
Primary antibodies for PLZF and GAPDH were respectively
purchased from Calbiochem (Darmstadt, Germany) and AbFron-
tier (Seoul, Korea).
Cell culture
The HUVEC line was purchased from the Bioresource
Collection and Research Center (Hsinchu, Taiwan), and cultured
in 90% medium 199 with 25 U/ml heparin and 30 mg/ml
endothelial cell growth supplement (ECGS) adjusted to contain
1.5 g/L sodium bicarbonate with 10% fetal bovine serum. They
were grown until the monolayer became confluent. The medium
for culturing cells was then changed to serum-free medium, and
cells were incubated overnight before the experiment. Cell culture
reagents were obtained from Sigma-Aldrich (St. Louis, MO,
USA).
FIR exposure
A ceramic FIR generator, a WS TY301 FIR emitter (WS Far
Infrared Medical Technology, Taipei, Taiwan), was used to
provide FIR exposure. This FIR emitter generates electromagnetic
waves with wavelengths in the range of 3,25 mm. HUVECs were
cultured in a 6-cm Petri dish with 3 ml medium for FIR exposure.
During FIR exposure, an experimental group and a negative
control covered with aluminum foil were set up in a culture
chamber of a LiveCell
TM system (Pathology Devices, Westminster,
MD, USA) at 37uC with a 5% CO2 atmosphere. The FIR
intensity was adjusted by changing the distance between the FIR
emitter and culture chamber. The effective FIR intensity and
wavelength received by HUVECs in culture dishes were detected
and calculated by China National Infrared & Industrial Electro-
thermal Products Quality Supervision & Test Center (Wuhan,
China). The effective primary FIR emission that the culture cells
received ranged 3,5 mm. Additionally, as a result of FIR
exposure, there was secondary emission from the Petri dish lids
with a peak wavelength of approximately 10 mm, calculated
according to Wein’s law.
Cell proliferation assay
HUVECs (10
4 cells/well) were cultured in a 96-well microtiter
plate in a final volume of 100 ml/well of culture medium. After
FIR exposure, cells were incubated at 37uC overnight. Cell
proliferation was analyzed using a Quick Cell Proliferation Assay
kit according to the instructions provided by the manufacturer
(BioVision, Mountain View, CA, USA), and results are presented
as the absorbance of each sample at 440 nm.
Western blot analysis
In total, 15 mg of HUVEC lysate proteins was applied to each
lane and analyzed by Western blotting. Peroxidase-conjugated
anti-rabbit or anti-mouse immunoglobulin G (IgG) (at a 1:5000
dilution) was used as the second antibody to detect primary
antibodies by enhanced chemiluminescence (Thermo Scientific,
Rockford, IL, USA). Data of protein bands on Western blots were
also quantitated with QuantiScan software (Biosoft, Cambridge,
UK).
Measurement of nitrate/nitrite levels
Nitrate/nitrite in the culture medium was measured as
described in a previous report [17]. In brief, a sample of medium
was deproteinized with two volumes of 99% ethanol at 4uC,
centrifuged (3,000 g for 10 min), and then injected into a
collection chamber containing 5% VCl3. This strong reducing
environment converted both nitrate and nitrite to nitric oxide
(NO). A constant stream of helium gas carried the NO into an NO
analyzer (Seivers 270B NOA; Seivers Instruments, Boulder, CO,
USA), where the NO reacted with ozone, resulting in the emission
of light. The light emitted was proportional to the quantity of NO
formed; standard amounts of nitrate were used for calibration.
Detection of intracellular reactive oxygen species (ROS)
Intracellular ROS production was detected with a fluorescent
microscope using the fluorescent dye, 29,79-dichlorofluorescein
diacetate (DCF-DA) (Molecular Probes, Eugene, OR, USA). Cells
were cultured overnight on 4-well chamber slides (Nalge Nunc
International, Naperville, IL, USA) at a concentration of 5610
3
cells per 400 ml culture medium. Before the experimental
treatment, slides were preincubated with 10 mM DCF-DA at
37uC for 30 min in the dark, and then subjected to experiments.
Fluorescence was observed by fluoromicroscopy with excitation
and emission wavelengths of 485 and 530 nm, respectively.
Nitrotyrosine formation assay
Nitrotyrosine formation was measured using Nitrotyrosine
ELISA kits (Millipore, Billerica, MA, USA), following the
manufacturer’s instructions. A standard curve was used to
determine the absolute concentration. Values were standardized
to micrograms of protein for each sample.
Phosphatase and tensin homolog (PTEN) activity assay
HUVECs were lysed at 4uC in lysis buffer (50 mM Tris,
pH 7.5, 1% Nonidet P-40, 0.5% sodium deoxycholate, 150 mM
NaCl, protease inhibitors). PTEN was collected by using
immunoprecipitation kits (Roche Molecular Biochemicals, Mann-
heim, Germany) with specific antibodies and protein-G-agarose,
following the manufacturer’s instructions. Precipitates were
washed with lysate buffer, and the activity of PTEN was analyzed
by using PTEN Malachite Green Assay Kit (Upstate, Lake Placid,
NY, USA). Absorbance was detected at 600 nm. Released
phosphate was determined relative to a standard curve.
RNA extraction and quantitative polymerase chain
reaction (qPCR) analysis
Total RNA was extracted from HUVECs using the TRIzol
method according to the protocol recommended by the manufac-
FIR Induces the Nuclear Translocation of PLZF
PLoS ONE | www.plosone.org 2 January 2012 | Volume 7 | Issue 1 | e30674turer (Invitrogen, Carlsbad, CA, USA), and used to synthesize single-
stranded complementary (c)DNA with a High-Capacity cDNA
Reverse Transcription Kit (Applied Biosystems, Foster City, CA,
USA). PI3K p85 subunit messenger (m)RNAs were quantified using
TaqMan Gene Expression Master Mix (Applied Biosystems) with
specific primers in an ABI 7300 Real-Time PCR System (Applied
Biosystems). TaqMan Gene Expression Assay kits containing specific
primers for PI3K p85-a (cat. no. Hs00933163_m1), PI3K p85-b (cat.
no. Hs00178181_m1), and GAPDH (cat. no. Hs99999905_m1)
were obtained from Applied Biosystems. Specific primers for
GAPDH were used to normalize the amount of sample added.
Relative amounts of PI3K p85 mRNA were quantitated using the
comparative Ct method. All quantifications were performed on
triplicate samples of three separate experiments.
Nuclear protein purification
HUVECs were suspended in cold buffer A (containing 10 mM
KCl, 0.1 mM EDTA, 1 mM DTT, and 1 mM PMSF) for 15 min,
lysed by adding 10% NP-40, and then centrifuged at 50006g to
obtain nuclear pellets. The nuclear pellets were resuspended in
cold buffer B (containing 20 mM HEPES, 1 mM EDTA, 1 mM
DTT, 1 mM PMSF, and 0.4 mM NaCl), vigorously agitated, and
then centrifuged.
Short interfering (si)RNA transfection
PLZF siRNA (cat. no. sc-37149) and control siRNA (cat. no. sc-
44234) were purchased from Santa Cruz Biotechnology. Cells
were grown to 70% confluence, and PLZF siRNA and control
siRNA were transfected using the TurboFect reagent according to
the manufacturer’s instructions (Fermentas, Glen Burnie, MD,
USA). The final concentration of PLZF siRNA for transfection
was 100 nM.
Statistical analysis
A Student’s t-test was used in all statistical tests. Distributions of
continuous variables in groups were expressed as the mean6S.D.
A value of p of ,0.05 was considered to indicate statistical
significance.
Results
FIR inhibits VEGF-induced proliferation in HUVECs
To evaluate the biological effects of FIR, VEGF-pretreated
HUVECs were exposed to 0.13 mW/cm
2 of FIR for 30 min and
then cultured overnight. A cell proliferation analysis revealed that
both VEGF and FIR exposure significantly increased cell
proliferation in HUVECs (Fig. 1A). However, FIR exposure
significantly inhibited VEGF-induced proliferation in HUVECs.
In an intensity course analysis, effective FIR intensities of 0.13, 0.8,
Figure 1. The influence of far infrared (FIR) exposure on VEGF-
induced proliferation in HUVECs. (A) The influence of VEGF and FIR
on cell proliferation. HUVECs were pretreated with VEGF (10 ng/ml)
with or without FIR exposure at 0.13 mW/cm
2 for 30 min, and then
cultured overnight. Cell proliferation results are presented as the
absorbance of each sample at 440 nm. (B) The influence of FIR intensity
on VEGF-induced cell proliferation. VEGF-pretreated cells were exposed
to FIR at the indicated intensity for 30 min, and then cultured overnight.
*p,0.05 vs. the control without FIR exposure. (C) The influence of FIR
exposure time on VEGF-induced cell proliferation. VEGF-pretreated cells
were exposed to FIR at 0.13 mW/cm
2 for the indicated periods, and
then cultured overnight. *p,0.05 vs. the control without FIR exposure.
(D) Western blotting of VEGF-induced phosphorylation of ERK1/2.
HUVECs were pretreated with or without VEGF (10 ng/ml) for 30 min,
exposed to FIR at 0.13 mW/cm
2 for the indicated periods, and then
cultured for 8 h. ERK1/2 was detected as a loading control. By
comparison with the control without FIR exposure, the relative levels
of phospho-ERK1/2 were obtained and are shown as the mean6S.D.
from six determinations in three cell preparations. *p,0.05 vs. the
control without FIR exposure.
#p,0.05 vs. the VEGF-treated group
without FIR exposure.
doi:10.1371/journal.pone.0030674.g001
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2 significantly reduced VEGF-induced prolifer-
ation (Fig. 1B). This inhibitory effect of FIR peaked at the effective
intensity of 0.13 mW/cm
2 and decreased at higher FIR intensities.
When the effective intensity rose to 7.20 mW/cm
2, FIR failed to
reduce VEGF-induced proliferation in HUVECs. Therefore, we
applied 0.13 mW/cm
2 as the working intensity in subsequent
experiments. In a time course analysis, the inhibitory effect of FIR
peaked at 30 min and decreased with longer exposure times
(Fig. 1C). A western blot analysis was also used to evaluate the
influence of FIR exposure on VEGF-activated extracellular signal-
regulated kinase (ERK)1/2. As shown in Fig. 1D, FIR exposure
significantly inhibited the phosphorylation of ERK1/2. Similar to
the inhibitory effect of FIR on cell proliferation, the inhibitory
effect of FIR on the phosphorylation of ERK1/2 peaked at 30 min
of FIR exposure, and gradually decreased at longer exposure
times.
The inhibitory effect of FIR on VEGF-induced proliferation
is associated with eNOS-mediated NO generation
A western blot analysis revealed that both VEGF and FIR
exposure induced the phosphorylation of eNOS in HUVECs
(Fig. 2A). FIR exposure further increased the phosphorylation of
eNOS in VEGF-treated HUVECs. This induction peaked at
30 min and gradually decreased at longer exposure times. When
we monitored the concentration of NO in the culture medium,
FIR exposure further induced NO generation by HUVECs
although VEGF also induced NO generation (Fig. 2B). These
increases in NO generation were inhibited by NG-nitro-L-arginine
methyl ester (L-NAME), an inhibitor of NOS. In cell proliferation
tests, FIR exposure slightly increased the cell proliferation of
HUVECs without VEGF treatment, but mitigated VEGF-induced
proliferation (Fig. 2C). In L-NAME-treated HUVECs, VEGF-
induced proliferation significantly decreased, and there was no
further decrease due to FIR exposure. L-NAME also reduced
VEGF-induced phospho-ERK1/2, which was not influenced by
FIR exposure (Fig. 2D).
The influence of a thermal effect on VEGF-induced
proliferation differed from that of FIR
A thermal effect of FIR on the cell culture system was also
examined in this study. With FIR exposure at different effective
intensities, we detected the temperature of 3 ml of culture medium
Figure 2. Involvement of eNOS and NO in the biological effect
of FIR in HUVECs. (A) Western blotting of phospho-eNOS. HUVECs
were pretreated with or without VEGF (10 ng/ml), exposed to FIR at
0.13 mW/cm
2 for the indicated periods, and then cultured for 1 h. We
detected eNOS as a loading control, and quantified phospho-eNOS
expression relative to eNOS. By comparison with the control without FIR
exposure, relative levels of phospho-eNOS were obtained and are
shown as the mean6S.D. from six determinations in three cell
preparations. *p,0.05 vs. the control with FIR exposure for 0 min.
#p,0.05 vs. the VEGF-treated group with FIR exposure for 0 min. (B)
Detection of FIR-induced NO. HUVECs were pretreated with VEGF and
NG-nitro-L-arginine methyl ester (L-NAME) (5 mM) as indicated,
exposed to FIR for 30 min, and then cultured for 1 h. The NO
concentration in cultured medium was detected by a nitric oxide
analyzer. (C) The influence of L-NAME on cell proliferation in HUVECs.
HUVECs treated as indicated were cultured overnight. Data are shown
as the mean6S.D. from six experiments. (D) Western blotting of
phospho-ERK1/2. HUVECs treated as indicated were cultured for 8 h.
ERK1/2 was detected as a loading control. By comparison with the
control without FIR exposure, relative levels of phospho-ERK1/2 were
obtained and are shown as the mean6S.D. from six determinations in
three cell preparations.
doi:10.1371/journal.pone.0030674.g002
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of 0.13 mW/cm
2 only mildly heated the culture system, and raised
the temperature of the medium from 37.060.1 to 37.160.1uCi n
30 min (Fig. 3A). The higher effective FIR intensity of 7.2 mW/
cm
2 had a strong heating effect, which raised the temperature of
the medium from 37.060.1 to 38.460.1uC in 30 min. The
temperature of the medium rose along with the FIR intensity and
exposure time. To evaluate the thermal effect on cell proliferation,
we cultured VEGF-pretreated HUVECs at different temperatures
for 30 min without FIR exposure, and detected VEGF-induced
cell proliferation after overnight culture. As shown in Fig. 3B,
pretreatment at 38,39uC slightly increased VEGF-induced
proliferation in HUVECs. A western blot analysis revealed that
pretreatment at 38,39uC did not influence VEGF-induced
expression of phospho-ERK1/2 or phospho-eNOS although
39uC pretreatment induced eNOS expression (Fig. 3C). These
expression patterns of phospho-ERK1/2 and phospho-eNOS
differed from FIR-induced events.
The inhibitory effect of FIR on VEGF-induced proliferation
involved VEGF-induced ROS generation
Intracellular ROS detection showed that VEGF-induced ROS
generation in HUVECs was significantly inhibited by an NADPH
oxidase inhibitor, apocynin, and a hydroxyl radical scavenger,
dimethylthiourea (DMTU), but was not influenced by FIR
exposure (Fig. 4A). Both apocynin and DMTU inhibited VEGF-
induced proliferation in HUVECs (Fig. 4B). In ROS scavenger-
treated HUVECs with VEGF treatment, FIR exposure signifi-
cantly increased cell proliferation (Fig. 4B). This result reveals that
VEGF-induced ROS generation plays a role in the inhibitory
effect of FIR on VEGF-induced proliferation in HUVECs.
Additionally, NO reacts with superoxide anion radical to form
peroxynitrite. Intracellular peroxynitrite can modify proteins by
interacting with and nitrating tyrosine residues to form 3-
nitrotyrosine. We also monitored nitrotyrosine formation in
HUVECs treated with VEGF and FIR. As shown in Fig. 4C,
nitrotyrosine formation significantly increased in HUVECs treated
with VEGF and FIR together. Neither VEGF nor FIR alone
influenced nitrotyrosine formation in HUVECs.
FIR-induced eNOS phosphorylation involves PI3K-
dependent Akt activation
To understand the molecular mechanisms underlying FIR-
induced eNOS activation, we focused on PI3K-dependent
activation of Akt, a known eNOS kinase. As shown in Fig. 5A,
both FIR and VEGF increased Akt phosphorylation in HUVECs,
and FIR further increased Akt phosphorylation in VEGF-treated
cells. The PI3K/Akt pathway inhibitor, wortmannin, abolished
Akt phosphorylation in VEGF-treated HUVECs with or without
FIR exposure. Similar to the expression of Akt phosphorylation,
wortmannin also significantly inhibited eNOS phosphorylation in
VEGF-treated HUVECs with or without FIR exposure (Fig. 5B).
FIR upregulated PI3K expression
The influence of FIR on PI3K signaling pathways was
investigated by monitoring phosphatase and tensin homolog
(PTEN) protein activity and PI3K expression. PTEN is a
phosphatase which inhibits Akt signaling pathways. However,
there was no influence of FIR on PTEN activity in HUVECs
(Fig. 6A). A western blot analysis revealed that FIR but not VEGF
significantly increased expression levels of PI3K p85 (Fig. 6B). The
results of the qPCR showed that mRNA levels of PI3K p85-a and
p85-b subunits significantly increased during FIR exposure, but
gradually decreased after FIR exposure (Fig. 6C). This result
reveals that FIR exposure upregulates the transcription of the
PI3K gene in HUVECs.
FIR exposure induced the nuclear translocation of PLZF
in HUVECs
PI3K-p85 is known to be positively regulated by PLZF [18]. We
further monitored the influence of FIR exposure on PLZF
Figure 3. Influence of a thermal effect on VEGF-induced
proliferation in HUVECs. (A) FIR exposure-increased the temperature
of the culture medium. The temperature of 3 ml of culture medium in
6-cm culture dishes was detected after FIR exposure at 0.13, 1.8, or
7.2 mW/cm
2 for the indicated periods. (B) The influence of thermal
pretreatment on VEGF-induced cell proliferation. HUVECs were
pretreated with VEGF (10 ng/ml), cultured at the indicated temperature
for 30 min, and then cultured at 37uC overnight. Data are shown as the
mean6S.D. from six experiments. * p,0.05 vs. the group at 37uC. (C)
Western blotting of phospho-ERK1/2, ERK1/2, phospho-endothelial
nitric oxide synthase (eNOS), and eNOS. HUVECs were pretreated with
VEGF, cultured at the indicated temperature for 30 min, and then
cultured at 37uC for 8 h. GAPDH was detected as a loading control.
doi:10.1371/journal.pone.0030674.g003
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induced the translocation of PLZF to nuclei in HUVECs. This
translocation almost disappeared after FIR exposure for 30 min.
VEGF and treatments at 38 and 39uC did not induce PLZF
translocation. We used PLZF siRNA transfection to block PLZF
expression in HUVECs, and then found that FIR exposure failed
to elevate mRNA levels of the PI3K p85-a and p85-b subunits
(Fig. 7B). PLZF siRNA transfection blocked FIR-induced
proliferation and the inhibitory effect of FIR on VEGF-induced
proliferation in HUVECs (Fig. 7C). PLZF siRNA transfection also
reduced FIR-induced eNOS phosphorylation, but did not
influence VEGF-induced eNOS phosphorylation (Fig. 7D). These
results reveal that PLZF activation plays a critical role in the
biological effects of FIR.
Figure 4. Involvement of VEGF-induced ROS in the inhibitory effect of FIR on VEGF-induced proliferation in HUVECs. (A) Detection of
VEGF-induced intracellular reactive oxygen species (ROS). HUVECs were incubated for 30 min with culture medium containing DCF, and then treated
with 10 ng/ml VEGF, 1 mM apocynin (Apo), 10 mM dimethylthiourea (DMTU), or FIR exposure at 0.13 mW/cm
2 for 30 min as indicated. Cells were
observed by fluoromicroscopy with excitation and emission wavelengths of 485 and 530 nm, respectively, and a photomicrograph is shown in the
right panel of each group. Scale bar=50 mm. (B) The influence of ROS scavengers on VEGF-induced cell proliferation. HUVECs were pretreated as
indicated, and then cultured overnight. Data are shown as the mean6S.D. from six experiments. * p,0.05 vs. the group treated with VEGF alone.
#p,0.05 vs. the group treated with VEGF and FIR exposure. (C) Detection of nitrotyrosine formation. HUVECs were pretreated as indicated, and then
cultured for 1 h. The nitrotyrosine formation data obtained from ELISA measurements are expressed as relative quantity (means6S.D. of 9
determinations in three cell preparations).
doi:10.1371/journal.pone.0030674.g004
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Based on our results, the FIR exposure at 0.13 mW/cm
2 for
30 min achieved the maximum inhibitory effect of FIR on VEGF-
induced proliferation in HUVECs. A higher FIR intensity or
longer exposure time was unable to increase the inhibitory effect of
FIR. FIR exposure also reduced VEGF-induced ERK1/2
phosphorylation, and increased the phosphorylation of eNOS.
Applications of the NOS inhibitor and ROS scavengers showed
that the inhibition effect of FIR was associated with eNOS-
mediated NO and VEGF-induced ROS. Although FIR exposure
usually accompanies thermal transmission, we found thermal
pretreatments slightly increased VEGF-induced proliferation in
HUVECs. The thermal effect of 38 or 39uC did not influence
phosphorylation levels of ERK1/2 or eNOS. Compared to the
influence of FIR on the eNOS signaling pathway, these results
show that the biological effects of FIR in HUVECs do not result
from a thermal effect. Moreover, we found that FIR exposure
induced the nuclear translocation of PLZF which increased PI3K
expression. This PI3K increase activated Akt which phosphory-
lated eNOS to generate NO in HUVECs. Pretreatment at 38 or
39uC did not induce PLZF translocation. Therefore, a non-
thermal effect of FIR inhibits VEGF-induced proliferation via
PLZF activation.
Figure 5. The influence of wortmannin on FIR-induced eNOS
phosphorylation in HUVECs. HUVECs were pretreated with vascular
endothelial growth factor (VEGF) (10 ng/ml), wortmannin (1 mM), or FIR
exposure for 30 min as indicated, and then cultured for 1 h. (A) Western
blotting of phospho-Akt. (B) Western blotting of phospho-eNOS. Akt
and eNOS were detected as loading controls, and quantified phospho-
eNOS and phospho-Akt expression relative to eNOS and Akt
respectively. By comparison with the control without FIR exposure,
relative levels of phospho-eNOS and phospho-Akt were obtained and
are shown as the mean6S.D. from six determinations in three cell
preparations. * p,0.05 vs. the control without FIR exposure.
doi:10.1371/journal.pone.0030674.g005
Figure 6. The influence of FIR on the PI3K signaling pathway in
HUVECs. (A) FIR exposure-influenced phosphatase and tensin
homolog (PTEN) activity. HUVECs were treated with vascular endothelial
growth factor (VEGF) (10 ng/ml) or FIR exposure as indicated for
30 min. PTEN activity in each sample was detected by PTEN Malachite
Green Assay Kit. The relative level of FIR-induced PTEN activity is shown
as the mean6S.D. from six experiments. (B) Western blotting of PI3K
p85. GAPDH was detected as a loading control. (C) FIR exposure-
induced RNA levels of PI3K p85. HUVECs were pretreated with FIR
exposure for 30 min, and then cultured for the indicated periods. The
mRNA quantity of PI3K in each sample was detected by a qPCR with
specific primers for the PI3K subunits p85a and p85b. The relative
mRNA level of FIR-induced PI3K is shown as the mean6S.D. from six
experiments. C, control. * p,0.05 vs. the control without FIR exposure.
doi:10.1371/journal.pone.0030674.g006
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It comprises 673 amino acids and contains nine Kruppel-like
C2H2 zinc finger domains and a POZ/BTB protein-binding
domain [19,20]. PLZF was identified as a chromosomal fusion
partner with retinoic acid receptor (RAR)a in acute promyelocytic
leukemia, a disease marked by an accumulation of undifferentiated
myeloid blasts [20,21]. Although RARa activates key genes
required for normal myelopoiesis, the PLZF-RARa fusion protein
represses the expression of some of these genes in a dominant
negative manner. Senbonmatsu et al. reported that angiotensin II
stimulation provokes internalization of angiotensin II type 2
receptor and PLZF, and translocation of PLZF to the nucleus [18].
Nuclear PLZF activates the PI3K p85-a gene leading to
subsequent activation of protein synthesis. Schefe et al. demon-
strated a novel renin/prorenin receptor (RR) signal transduction
pathway involving direct protein-protein interactions between the
RR and PLZF, and the nuclear translocation of PLZF upon renin
stimulation [22]. Downstream effects of RR activation by renin
include repression of the RR itself and induction of the PI3K p85-
a subunit. In the present study, we also found that the nuclear
translocation of PLZF induced expressions of the PI3K p85-a and
p85-b subunits at the transcriptional level. However, no study has
revealed the connection between FIR exposure and PLZF. Our
findings provide the first evidence that FIR exposure induces the
nuclear translocation of PLZF in HUVECs. FIR exposure may
exert multiple biological functions in HUVECs via the nuclear
translocation of PLZF.
NO is a free radical species that diffuses and concentrates in the
hydrophobic core of low-density lipoproteins to serve as a potent
antioxidant [23]. Endothelium-derived NO is a paracrine factor
that controls vascular tone, inhibits platelet function, prevents
leukocyte adhesion, and reduces intimal proliferation [24].
Endothelial NOS-mediated NO generation also plays a crucial
role in the process of VEGF-induced angiogenesis [25]. Our
results showed that the NOS inhibitor, L-NAME, inhibited both
VEGF-induced NO generation and proliferation in HUVECs.
FIR-induced NO generation also increased HUVEC proliferation
without VEGF treatment (Fig. 2). However, a higher concentra-
tion of NO induced by FIR and VEGF together did not induce
greater HUVEC proliferation, but showed an inhibitory effect
instead. The influence of NO on HUVEC proliferation may be
concentration-dependent. Additionally, VEGF-induced ROS
plays a role in inhibiting HUVEC proliferation while treating
with FIR and VEGF together (Fig. 4B). In principle, a high
concentration of NO can react with VEGF-induced ROS to
Figure 7. Involvement of the promyelocytic leukaemia zinc
finger (PLZF) in the biological effect of FIR. (A) Western blotting of
nuclear PLZF in HUVECs. HUVECs were treated as below: 1, none; 2, FIR
exposure for 30 min; 3, FIR exposure for 30 min and then culture for
30 min; 4, VEGF (10 ng/ml) treatment alone for 30 min; 5, 38uC culture
alone for 30 min; 6, 39uC culture alone for 30 min. Nuclear proteins
were extracted and detected with a PLZF monoclonal antibody. Nuclear
matrix protein p84 was detected as a loading control. By comparison
with the control without FIR exposure, relative levels of nuclear PLZF
were obtained and are shown as the mean6S.D. from six determina-
tions in three cell preparations. * p,0.05 vs. the control without FIR
exposure. (B) PLZF siRNA transfection-influenced RNA levels of PI3K p85.
HUVECs were transfected with PLZF siRNA (sR) or mock control RNA (M).
PLZF expression was monitored by a western blot analysis. Transfected
cells were treated with or without FIR exposure as indicated for 30 min.
The mRNA quantity of PI3K in each sample was detected by a qPCR
with specific primers for PI3K subunits p85a and p85b. The relative
mRNA level of FIR-induced PI3K is shown as the mean6S.D. from six
experiments. * p,0.05 vs. the mock control with FIR exposure. (C) PLZF
siRNA transfection-influenced cell proliferation in HUVECs. Transfected
cells were pretreated with VEGF (10 ng/ml) or FIR exposure as indicated
for 30 min, and then cultured overnight. Data are shown as the
mean6S.D. from six experiments. (D) PLZF siRNA transfection-
influenced phospho-eNOS in HUVECs. Transfected cells were treated
as indicated and then cultured for 1 h. We detected eNOS as a loading
control, and quantified phospho-eNOS expression relative to eNOS. By
comparison with the mock control without VEGF treatment and FIR
exposure, relative levels of phospho-eNOS were obtained and are
shown as the mean6S.D. from six determinations in three cell
preparations.
doi:10.1371/journal.pone.0030674.g007
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product of the diffusion-limited reaction between NO and
superoxide anions, mediates oxidative modifications in lipid
systems including cell membranes and lipoproteins [26]. Intracel-
lular peroxynitrite can modify proteins by interacting with and
nitrating tyrosine residues to form 3-nitrotyrosine. Our results
showed that the combination of FIR and VEGF treatments
significantly induced nitrotyrosine formation in HUVECs
(Fig. 4C). Peroxynitrite exhibits a wide array of tissue-damaging
effects ranging from lipid peroxidation, inactivation of enzymes
and ion channels via protein oxidation and nitration to inhibition
of mitochondrial respiration [27]. Agbani et al. found that .2 mM
peroxynitrite caused apoptotic cell death independent of p38 MAP
kinase activation in pulmonary artery cells [28]. Therefore, the
mechanisms of lipid oxidation and nitration by peroxynitrite
induced by FIR and VEGF together may interfere with HUVEC
proliferation.
FIR therapy was found to improve inadequate access flow and
survival of an AVF in HD patients, although the mechanism of its
non-thermal effects is still unknown [6]. Malfunction of vascular
access results primarily from venous stenosis, which is caused by
intimal hyperplasia with subsequent impairment of blood flow and
a thrombosis [7]. It is possible that the NO-mediated inhibitory
effect of FIR on VEGF-induced proliferation in vascular
endothelial cells can reduce VEGF-mediated intimal hyperplasia
with hemodialysis graft placement. Additionally, NO induces
vasodilation, inhibits platelet aggregation, prevents neutrophil/
platelet adhesion to endothelial cells, inhibits smooth muscle cell
proliferation and migration, regulates programmed cell death, and
helps maintain the endothelial cell barrier function [29]. Thus,
NO bioavailability is crucial for maintaining vascular endothelial
health and function [30]. In theory, FIR therapy can reduce
intimal hyperplasia, prevent venous stenosis, and increase access
flow of the AVF in HD patients via PI3K/Akt-activated NO
generation, and is also a potential remedy for other vascular
disorders such as peripheral obstructive arterial disease.
Because thermal transmission always accompanies FIR emis-
sion, FIR therapy often possesses a thermal effect. In this study, we
evaluated the thermal effect at temperatures (37,39uC) generated
by FIR exposure. Unlike the biological effect of FIR, the thermal
effect slightly increased VEGF-induced proliferation in HUVECs.
The influence of the thermal effect differed from the biological
effect of FIR on PLZF translocation and PI3K/Akt signaling
pathways. Actually, the increase in FIR intensity or exposure time
gradually reduced the inhibitory effect of FIR. This may have
resulted from the thermal effect caused by FIR exposure because
the increase in FIR intensity or exposure time significantly raised
the temperature of the culture medium. Thus, we suggest that the
temperature increase should be limited in FIR therapy on AVFs in
HD patients to achieve maximum therapeutic effects.
In conclusion, the present study reveals that FIR exposure
induced the nuclear translocation of PLZF which upregulated
PI3K to activate Akt, and then activated eNOS to induce NO
generation. This NO generation combined with VEGF-induced
ROS generation resulted in inhibition of VEGF-induced prolifer-
ation in HUVECs. Through a PLZF-mediated pathway, FIR
therapy is a potential therapeutic modality to maintain vascular
endothelial health and function.
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